M&T BANK CORP - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
M&T BANK CORP ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$2,246,000
+14.7%
11,481
-0.4%
0.01%
+10.0%
Q2 2020$1,959,000
+48.2%
11,529
+0.6%
0.01%
+25.0%
Q1 2020$1,322,000
+10.9%
11,458
+9.8%
0.01%
+33.3%
Q4 2019$1,192,000
-21.1%
10,437
-41.1%
0.01%
-25.0%
Q3 2019$1,511,000
+22.6%
17,711
-0.5%
0.01%
+33.3%
Q2 2019$1,232,000
-8.8%
17,794
-3.6%
0.01%
-14.3%
Q1 2019$1,351,000
+31.5%
18,462
+1.8%
0.01%
+16.7%
Q4 2018$1,027,000
-25.8%
18,132
+1.0%
0.01%
-14.3%
Q3 2018$1,385,000
+541.2%
17,944
+330.0%
0.01%
+600.0%
Q2 2017$216,000
-21.7%
4,173
-4.6%
0.00%
-50.0%
Q1 2017$276,000
+27.2%
4,376
+7.3%
0.00%
+100.0%
Q4 2016$217,000
+1.4%
4,079
+3.2%
0.00%0.0%
Q3 2016$214,000
-43.8%
3,951
-53.5%
0.00%
-66.7%
Q4 2015$381,000
+52.4%
8,500
+31.2%
0.00%
+50.0%
Q3 2015$250,000
-19.9%
6,479
+0.5%
0.00%0.0%
Q2 2015$312,000
+38.7%
6,446
+1.5%
0.00%
+100.0%
Q1 2015$225,000
-20.5%
6,350
-27.9%
0.00%
-50.0%
Q4 2014$283,000
-33.1%
8,810
-22.7%
0.00%
-33.3%
Q3 2014$423,000
+1013.2%
11,403
+1040.3%
0.00%
+50.0%
Q2 2014$38,000
-17.4%
1,0000.0%0.00%0.0%
Q1 2014$46,000
+15.0%
1,0000.0%0.00%0.0%
Q4 2013$40,0001,0000.00%
Other shareholders
SEATTLE GENETICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 57,170$10,013,0005.39%
Boxer Capital, LLC 400,000$70,056,0002.25%
PARTNERS CAPITAL INVESTMENT GROUP, LLP 110,153$19,292,0001.10%
DCF Advisers, LLC 13,300$2,329,0000.96%
XTX MARKETS LLC 2,418$423,0000.87%
FAIRFIELD, BUSH & CO. 15,035$2,633,0000.77%
Parcion Private Wealth LLC 4,520$792,0000.10%
Gulf International Bank (UK) Ltd 26,091$4,569,0000.06%
Princeton Portfolio Strategies Group LLC 1,500$263,0000.05%
Redpoint Investment Management Pty Ltd 2,392$419,0000.04%
View complete list of SEATTLE GENETICS INC shareholders